2022
DOI: 10.1148/radiol.210567
|View full text |Cite
|
Sign up to set email alerts
|

CT in Transcatheter-delivered Treatment of Valvular Heart Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 99 publications
0
18
0
Order By: Relevance
“…Despite ongoing efforts for developing dedicated TMVR devices and distinct implantation techniques, along with reliable pre-procedural imaging, 8 , 9 LVOT-O remains a major exclusion criterion in native TMVR. 10 In recent clinical trials, around 50% of patients were excluded based on LVOT-O and/or anatomical considerations.…”
Section: Discussionmentioning
confidence: 99%
“…Despite ongoing efforts for developing dedicated TMVR devices and distinct implantation techniques, along with reliable pre-procedural imaging, 8 , 9 LVOT-O remains a major exclusion criterion in native TMVR. 10 In recent clinical trials, around 50% of patients were excluded based on LVOT-O and/or anatomical considerations.…”
Section: Discussionmentioning
confidence: 99%
“…Cardiovascular imaging techniques are widely used and indispensable for the diagnosis and treatment of valvular heart disease. 13 Thus, dextrocardia is not difficult to diagnose clinically, and it is easy to identify such patients with CT and X-ray examinations. CT plays an important role in preoperative planning 13 because dextrocardia may be associated with an additional risk of cardiovascular abnormalities.…”
Section: Discussionmentioning
confidence: 99%
“…There is also growing evidence of its beneficial use in patients at intermediate or low-surgical risk [ 5 , 6 ]. The preprocedural planning for TAVR relies heavily on Electrocardiogram (ECG)-synchronized CT-angiography (CTA), which provides exact aortic annular sizing and the ideal access route evaluation [ 7 ], and can be used for post-procedural risk stratification [ 8 ]. Given the dynamic changes that the aortic annulus undergoes during the cardiac cycle, manufacturers base their heart valve sizing recommendations on systolic measurements, as this is when the annulus typically reaches its largest dimension [ 9 ].…”
Section: Introductionmentioning
confidence: 99%